Search Results
Results found for "chronic pain"
- Orthosteric vs. Allosteric Interactions: The Silent Decider of Safety and Success
That choice determines whether you risk over- or under-dosing, miss safety windows, or miss therapeutic In this session, you’ll gain: ✅Clarity on Definitions: What truly distinguishes orthosteric from allosteric
- Why Opposing Processes Matter for Your Next GPCR Drug
In this session, you’ll gain: ✅ A mental model you can trust for predicting how GPCR ligands behave
- 📰 GPCR Weekly News, February 13 to 19, 2023
Mandibulofacial dysostosis with alopecia results from ETAR gain-of-function mutations via allosteric
- GPCR News Flash! Top Updates You Can't-Miss! + University CheatSheet is finally available! ❄ Dec 2 - 8, 2024
As a Premium Member, you gain exclusive access to this incredible treasure trove we've amassed over the
- Extracellular signal-regulated kinases – a potential pathway for GPCR-targeted drug discovery
ERK activation pathways can be categorised into two main sub-pathways based on their subcellular localisation The choice of pathway can result in different cellular responses, underscoring the criticality of precise
- Unlocking the Therapeutic Potential of Previously Undruggable GPCRs
remaining non-sensory receptors, with functions more readily linked to pathology, are currently the main cell surface, or because they have an enhanced capacity to elicit receptor internalization, thereby gaining 17706–17711. https://doi.org/10.1073/pnas.0805098105 · Development and use of new technology to gain
- From DNA day to GPCR genomics
The G-protein-coupled receptors in the human genome form five main families.
- 📰 GPCR Weekly News, September 25 to October 1, 2023
Subscribe now to gain access to exclusive insights from Dr. GPCR Newsletter!
- Beyond Clearance: The Strategic Power of Irreversible Drug Binding
In this lesson, you'll gain: ✅ Clarity on what “irreversible” really means in kinetic and pharmacologic It’s a design space , not a binary choice, and penetration is just the beginning.
- 📰 GPCR Weekly News, March 11 to 17, 2024
Hoare's expert guidance, you will gain invaluable skills in data analysis.
- Biased Agonism at the GLP-1 Receptor: A Pathway to Improved Therapeutic Outcomes
This concept is gaining significant attention in drug discovery, especially in the context of G protein-coupled
- Assay Sensitivity: The Hidden Lever Driving GPCR Drug Discovery
In this course, you’ll gain: ✅ How assay volume control alters receptor sensitivity and what that
- 📰 GPCR Weekly News, August 28 to September 3, 2023
GPCR Newsletter to gain access to further insights!
- From Snapshots to Predictions: Why Mechanism of Action Matters
In This Session, You’ll Gain: ✅ How to turn descriptive snapshots into predictive insights ✅ Tools to What looked like four conflicting behaviors turned out to be one coherent mechanism , hidden in plain Unlock “Mechanism of Action” now Only in Terry’s Corner Why Terry’s Corner When early choices determine
- How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology
animals — a milestone that demonstrated just how powerful well-engineered chemical tools can be when paired JB gained a grounded understanding of tissue heterogeneity, signal variability, and the biology that
- 📢 Early Bird Registration Ends Tomorrow! | Sep 16 - 22, 2024
Gain access to over 500 minutes of recorded classes in our GPCR courses taught by Drs.
- Orthosteric Binding Experiments: How to Avoid the Most Common Data Pitfalls
In this session, you’ll gain: Why saturation and displacement assays fail when protein stoichiometry
- GPCR Pharmacology Insights That Prevent Real Drug Discovery Failures
In this session, you’ll gain: How system sensitivity transforms potency, efficacy, and agonist classification
- From Failed Experiments to Predictive GPCR Models
His introduction came through a practical suggestion: explore a new protein family that was gaining traction
- 📰 GPCR Weekly News, May 13 to 19, 2024
Dive into this fascinating topic and gain valuable insights from one of the leading experts in the field
- Targeting Intracellular Allosteric Sites in GPCRs
Allosteric modulation is gaining prominence in GPCR therapeutics, with the discovery of an intracellular
- High-Content Screening for GPCR Programs: Overcoming Assay Limitations with Fluorescent Ligands
Non-Radioactive Workflow By removing isotopes, researchers gain safer, more scalable, and more environmentally
- From Pipettes to Platforms: The Evolution of GPCR Research
These painstaking manual workflows laid the foundation for what would become the evolution of GPCR research
- GPCR Happy Hour – Boston, Sept 2025
electrophysiology platform, iPSC-derived models, optogenetics, and high-content screening techniques such as cell painting
- Fluorescence based HTS compatible ligand binding assays for dopamine D3 receptors in baculovirus preparations and live cells
Cy3B label of CELT-419, which fits well for FA and live-cell microscopy measurements, is not the best choice An Order of Magnitude Faster DNA-PAINT Imaging by Optimized Sequence Design and Buffer Conditions.
- Odorant receptors – a bit of smell for drug discovery
In the cardiovascular system, ORs have the potential to operate as the main carriers of endogenously
- Is Your Agonist Really “Working”—Or Are You Just Seeing What Your System Allows?
think batteries and balance scales), Terry reveals why different tissues—and even different assays—can paint
- Artificial intelligence – faster, smarter, cheaper GPCR drug discovery
The future According to the authors, the future of AI relies in 6 main areas: 1.


















